Clinical Trial Update: IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating IBI343 in combination with Sintilimab and chemotherapy for gastric cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• IBI343
• Sintilimab (sintilimab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: RECRUITING